A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Vasculotropin Receptor 3 100%
• Interferon 100%
• Natural Killer Cell 100%
• Lymph Duct 11%
• Cytokine 5%
• Flow Cytometry 5%
• Cell Therapy 5%
• Fluorescence Activated Cell Sorting 5%
• Immunohistochemistry 5%
• Reverse Transcription Polymerase Chain Reaction 5%
• Immunocompetent Cell 5%
• Cancer Cell 5%
• Effector Cell 5%
• De Novo Acute Myeloid Leukemia 5%

Immunology and Microbiology

• Interferon Type I 100%
• Natural Killer Cell 100%
• Myeloid 100%
• Vasculotropin 100%
• Effector Cell 5%
• Reverse Transcription Polymerase Chain Reaction 5%
• Immunocompetent Cell 5%
• Fluorescence Activated Cell Sorting 5%
• Cancer Cell 5%
• Immunostaining 5%
• Cytotoxicity 5%
• Cytokine 5%

Neuroscience

• Myeloid 100%
• Interferon 100%
• Vasculotropin Receptor 3 100%
• Natural Killer Cell 100%
• K562 Cells 11%
• Cytotoxicity Assay 5%
• Flow Cytometry 5%
• Immunohistochemistry 5%
• Cell Therapy 5%